The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.80
Bid: 38.80
Ask: 39.55
Change: 0.00 (0.00%)
Spread: 0.75 (1.933%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 38.80
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING: Zambeef sees profit above market views; Luceco trades in line

Tue, 07th Nov 2023 17:47

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Luceco PLC - London-based lighting manufacturer and distributor - Says that in the three months ended September 30, it traded in line with expectations. Revenue in the third quarter was 8.3% ahead of the prior year. Looking ahead, Luceco left its full-year guidance unchanged. Chief Executive Officer John Hornby says: "Whilst demand from energy saving professional projects continues its positive path; we are seeing some impact of reduced demand in certain of our end markets as the UK consumer continues to experience economic headwinds. Luceco's strong cash generation in the quarter was particularly encouraging, and with our low levels of net debt, the group is well placed to invest in growth and enhance earnings in line with strategic priorities."

----------

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Further expands partnership with M8 Pharmaceuticals Inc. Says M8 has taken up its rights to extend its licensing agreement from Brazil and Mexico to market MED3000 in a further fourteen countries throughout the Central and South American region. Futura has received an undisclosed upfront milestone payment from M8 as part of the extended agreement. The extension builds on the agreement signed in August 2021. Apart from the geographic expansion, the commercial terms and initial duration of the agreement remain unchanged. CEO James Barder says: "This is another major step forward in the execution of Futura's strategy. M8 is an excellent partner with dedicated brand-building and marketing experience, as well as scale and strong pharmaceutical connections in South and Central America and we look forward to working closely with them across the Latin American region."

----------

Vianet Group PLC - Stockton-on-Tees, England-based provider of retail sales and volume monitoring systems - Intends to conduct on-market purchases under a share buyback programme. The programme, which will be funded from its existing cash resources, is intended to reduce the share capital of the company. The buyback will begin immediately and will close at the conclusion of the 2024 annual general meeting, or September 5.

----------

Scotgold Resources Ltd - Stirlingshire, Scotland-based gold and silver exploration company's- Says it is considering the appointment of administrators "over the coming days." In October, Scotgold said it was in "advanced" financing discussions with a strategic investor, but now says the discussions "have not resulted in an investment at this time." Its share were suspended in September, pending clarification of its financial position.

----------

Zambeef Products PLC - Lusaka-based cold chain foods and retail business with operations in Zambia, Nigeria and Ghana - Says forward guidance on financial trading performance for the year ended September 30 is expected to be above market expectations, despite a challenging operating environment. Says revenue, gross profit and adjusted earnings before interest, tax, depreciation and amortisation are expected to be between 5-15% higher than market expectations. Reported pretax profit is expected to be about 30% higher than current market expectations. "The group continued to see increasing demand for its products, supported by a price moderation approach, resulting in volume growth across most product categories. Lower than expected selling prices and higher input costs (which couldn't fully be passed on to the consumer), including fuel and electricity, put pressure on gross margins which moderated in the second half," it says.

----------

F&C Investment Trust PLC - aims for long-term growth and income by investing in listed equities globally - Says that a third dividend for 2023 will be paid. Ups quarterly dividend to 3.40p from 3.20p a year earlier. Looking ahead, F&C plans to deliver another rise in our total dividend for this year, which will be the 53rd consecutive annual rise.

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
4 Sep 2014 15:10

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
13 May 2014 12:38

Futura Confident In Future, Gearing For Product Launches

LONDON (Alliance News) - Futura Medical PLC expressed confidence for its future, saying that by the end of 2014 two of its products are set to generate recurring revenues, in a statement ahead of its annual general meeting Tuesday. The biotechnology company said it is focused on driving pro

Read more
28 Mar 2014 10:28

Futura Medical Loss Widens As It Ramps Up For "Landmark" 2014

LONDON (Alliance News) - Futura Medical PLC expressed confidence for a "landmark" 2014 Friday, after it posted a wider loss in 2013 as it ramped up development of its product portfolio. The company posted a pretax loss of GBP2.52 million, widened slightly from GBP2.44 million in 2012, as a

Read more
10 Mar 2014 11:43

Futura Medical Says Condom To Be Launched In Several Countries In 2014

LONDON (Alliance News) - Futura Medical PLC Monday said it expects to launch its CSD500 condom in several countries in the second half of this year, including one launch using its own brand name, a rollout that will continue into 2015 and beyond. The biotechnology company has developed the

Read more
10 Mar 2014 08:26

UK MORNING BRIEFING: Shares Gain; Fyffes To Merge With Chiquita

LONDON (Alliance News) - Shares have opened higher Monday despite a weak lead from Asia.

M&A and share placings have grabbed attention at the open.

Chiquita Brands International Inc and Fyffes PLC said they will merge to create the world's largest ba

Read more
7 Mar 2014 18:16

Futura Medical Raises GBP12 Million In Share Placing

LONDON (Alliance News) - Futura Medical PLC Friday said it has raised GBP12.0 million through the conditional placing of 21.1 million shares in the company at a price of 57 pence per share. The healthcare company said it placed the shares with existing and new institutional investors and sa

Read more
27 Jan 2014 11:45

Futura In Talks With Commercial Partners As PET500 Product Launches In US

LONDON (Alliance News) - Futura Medical PLC said Monday it is continuing discussions with potential commercial partners ahead of the launch of its new CSD500 condom, as Ansell Ltd began the roll out of its PET500 product for premature ejaculation in the US. Ansell has exclusive worldwide ri

Read more
17 Jan 2014 16:54

Tesco Chairman keeps the faith after recent poor update

Tesco Non-Executive Chairman Sir Richard Broadbent added 10,000 shares to his stake, the supermarket chain announced Friday. Broadbent, who joined the board in July 2011, bought the shares at 331.22p a piece for a total spend of £33,122. The purchase was made less than a week after the company p

Read more
14 Jan 2014 15:22

Sector movers: AstraZeneca, Shire lift pharma stocks on upbeat guidance

Decent gains from AstraZeneca and Shire gave the pharmaceuticals sector a boost on Tuesday as both firms gave confident outlooks. At the JP Morgan Healthcare Conference in San Francisco, AstraZeneca Chief Executive Pascal Soriot said he expects the company to return to growth sooner than analysts c

Read more
17 Oct 2013 09:34

Futura Medical Gets European Marketing Approval For Novel Condom

Read more
24 Sep 2013 16:44

Regenersis CFO tops up stake as results impress

Jog Dhody, the Chief Financial Officer of Regenersis, on Tuesday acquired 39,000 ordinary shares in the outsourcing partner on the same day it posted "a strong financial performance and good growth" for the year ended June 30th. Dhody bought the shares a price of 255p per share, spending a total o

Read more
12 Sep 2013 10:46

Futura Medical Narrows Losses As New Condom Gets European Licences

Read more
12 Sep 2013 10:27

Futura Medical losses shrink as launch climax approaches - UPDATE

Losses contracted slightly at condom developer Futura Medical in the first half-year, as it continued to massage the costs of bringing its lead product towards the climax of market launch in 2014. Losses before tax shrank from £1.08m to £1.03m, as a net cash outflow of £0.7m saw the AIM company ho

Read more
9 Sep 2013 11:37

UK Winners & Losers: BG Down 5%, CSR Up 5%; Mediazest Drops 21%

Read more
2 Apr 2013 13:26

Futura Medical signs marketing and distribution deal with Church & Dwight

Futura Medical, a pharmaceutical group that develops innovative products for consumer healthcare, has signed an agreement with Church & Dwight Co., for the marketing and distribution of CSD500, Futura's new condom product under the Trojan brand. Under the terms of the agreement, Church & Dwight wi

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.